Opportunity Information: Apply for HRSA 11 061
Apply for HRSA 11 061
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White Part B HIV Care Grant Program" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917 HIV Care Formula Grants.
- This funding opportunity was created on Aug 25, 2010 and posted on Aug 25, 2010.
- Applicants must submit their applications by Jan 3, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,293,002,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 59 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The following States and Territories are eligible to apply for program funding all 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the Territories of the Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands. States must designate a lead State/Territory agency that will be responsible for administering all assistance received conducting a needs assessment and preparing a State/Territory plan preparing all applications receiving notices regarding programs and collecting and submitting to the Secretary every two years all audits from grantees within the State, including an audit regarding funds expended.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Ryan White Part B HIV Care Grant Program (Funding Opportunity Number HRSA-11-061) is a federal grant opportunity administered by the Health Resources and Services Administration (HRSA) to support HIV care, medications, and related support services for people with HIV who are low income and underserved. Authorized under Part B of the Ryan White HIV/AIDS Treatment Modernization Act, the program is designed to help States and Territories build, strengthen, and maintain a comprehensive continuum of HIV care. In practical terms, it is meant to close gaps in access to essential medical treatment and supportive services so that people living with HIV can stay in care, maintain viral suppression, and address related health and social needs.
Funding is available to all 50 U.S. States and a defined set of jurisdictions and territories: Washington, D.C.; the Commonwealth of Puerto Rico; the U.S. Virgin Islands; Guam; American Samoa; the Commonwealth of the Northern Mariana Islands; and the five Associated Jurisdictions in the Pacific (the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are specifically named among them). Applicants must be governmental entities at the State or Territory level, and each State or Territory is required to designate a lead agency responsible for administering the grant. That lead agency is expected to oversee core administrative duties such as conducting an HIV needs assessment, developing a State/Territory plan, preparing and submitting applications, receiving official communications, and handling reporting and audit coordination requirements. The announcement also notes an ongoing responsibility to collect and submit audits to the Secretary every two years, including audits related to the expenditure of funds.
The program’s purpose is broad and service-oriented. Funds can be used to support primary medical care and a range of HIV-related services that collectively form a “continuum of care.” This continuum includes, but is not limited to, HIV-related medications, mental health treatment, substance use treatment, oral health services, medical and non-medical case management, home health care, nutritional services, and rehabilitation services. The focus is not only on clinical treatment, but also on the wraparound services that help people remain engaged in care and adhere to treatment, especially when poverty, housing instability, behavioral health needs, or other barriers interfere with consistent access to healthcare.
A major centerpiece of Part B is ensuring access to antiretroviral therapy and other drug therapies. The program explicitly supports access to HIV medications, including therapies used to prevent and treat opportunistic infections and combination antiretroviral regimens. This medication access is commonly implemented through the AIDS Drug Assistance Program (ADAP), which is closely tied to Part B funding and is a primary mechanism States and Territories use to provide life-saving HIV medications to eligible clients.
This opportunity describes multiple funding streams or components within Part B. These include formula grants (often referred to as Part B base awards), ADAP-related funding for HIV/AIDS medications, and Supplemental ADAP funds that are targeted specifically to strengthen medication access. The announcement also references Emerging Communities grants, which are intended to help address HIV service needs in communities experiencing emerging or growing HIV burdens. In addition, the program includes Minority AIDS Initiative (MAI) funds, which are directed toward HIV-related outreach and education in communities of color that have been disproportionately affected by the epidemic. The MAI emphasis reflects the program’s intent to address persistent disparities in HIV incidence, access to care, and health outcomes.
From a grants administration standpoint, the opportunity is categorized as discretionary and uses the grant funding instrument type, with an activity category of Health. The CFDA number listed is 93.917 (HIV Care Formula Grants). The opportunity anticipated 59 awards and indicated no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of receiving the award. The estimated total funding amount listed for the opportunity was $1,293,002,000, underscoring the scale of the program and its central role in financing HIV care infrastructure at the State and Territory level.
Key dates in the notice show it was posted on August 25, 2010, with an original and current closing date of January 3, 2011, and an archive date of March 4, 2011. For assistance accessing the full announcement, HRSA provided support through the HRSA Call Center (CallCenter@HRSA.GOV and telephone contact options), and the source included a link to the archived posting on HRSA’s grants site.
Ryan White Part B HIV Care Grant Program (HRSA-11-061) FAQs
1) What is the Ryan White Part B HIV Care Grant Program (HRSA-11-061)?
The Ryan White Part B HIV Care Grant Program (Funding Opportunity Number HRSA-11-061) is a federal grant opportunity administered by the Health Resources and Services Administration (HRSA). It supports HIV care, HIV medications, and related support services for people living with HIV who are low income and underserved. The program is authorized under Part B of the Ryan White HIV/AIDS Treatment Modernization Act and is intended to help States and Territories build, strengthen, and maintain a comprehensive continuum of HIV care.
2) What is the main goal of this funding opportunity?
The program is designed to close gaps in access to essential medical treatment and supportive services so people living with HIV can stay in care, maintain viral suppression, and address related health and social needs. In practice, it funds both clinical care and wraparound services that help clients remain engaged in treatment when barriers like poverty, housing instability, or behavioral health needs make consistent care difficult.
3) Who can apply for HRSA-11-061?
Applicants must be governmental entities at the State or Territory level. Each State or Territory is required to designate a lead agency responsible for administering the grant.
4) Which locations are eligible for funding under this program?
Funding is available to all 50 U.S. States and a defined set of jurisdictions and territories, including Washington, D.C.; the Commonwealth of Puerto Rico; the U.S. Virgin Islands; Guam; American Samoa; the Commonwealth of the Northern Mariana Islands; and the five Associated Jurisdictions in the Pacific. The notice specifically names the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands among the Associated Jurisdictions.
5) What is the role of the designated State/Territory lead agency?
The designated lead agency is expected to administer the grant and handle core administrative responsibilities. These responsibilities include conducting an HIV needs assessment, developing a State/Territory plan, preparing and submitting applications, receiving official communications, and coordinating reporting and audit requirements.
6) Are there audit requirements tied to this program?
Yes. The announcement notes an ongoing responsibility to collect and submit audits to the Secretary every two years, including audits related to the expenditure of funds.
7) What types of services can Part B funds support?
The program supports primary medical care and a range of HIV-related services that together form a continuum of care. The notice states this continuum includes, but is not limited to: HIV-related medications, mental health treatment, substance use treatment, oral health services, medical and non-medical case management, home health care, nutritional services, and rehabilitation services.
8) Does the program pay for HIV medications?
Yes. A major centerpiece of Part B is ensuring access to antiretroviral therapy and other drug therapies. The program explicitly supports access to HIV medications, including therapies used to prevent and treat opportunistic infections and combination antiretroviral regimens.
9) What is ADAP and how does it relate to Part B?
ADAP stands for the AIDS Drug Assistance Program. The opportunity describes medication access as commonly being implemented through ADAP, which is closely tied to Part B funding and is a primary mechanism States and Territories use to provide HIV medications to eligible clients.
10) What funding components or streams are included in this opportunity?
The opportunity references multiple components within Part B, including formula grants (often called Part B base awards), ADAP-related funding for HIV/AIDS medications, Supplemental ADAP funds targeted specifically to strengthen medication access, Emerging Communities grants to address needs in communities with emerging or growing HIV burdens, and Minority AIDS Initiative (MAI) funds.
11) What are Emerging Communities grants in the context of Part B?
Emerging Communities grants are described as intended to help address HIV service needs in communities experiencing emerging or growing HIV burdens.
12) What are Minority AIDS Initiative (MAI) funds used for under this program?
The program includes Minority AIDS Initiative (MAI) funds, which are directed toward HIV-related outreach and education in communities of color that have been disproportionately affected by the epidemic. The MAI emphasis reflects an intent to address persistent disparities in HIV incidence, access to care, and health outcomes.
13) Is this opportunity formula-based, discretionary, or both?
The opportunity is categorized as discretionary and uses the grant funding instrument type. It also references formula grants (often referred to as Part B base awards) as one of the funding components.
14) What is the CFDA number for this program?
The CFDA number listed in the notice is 93.917 (HIV Care Formula Grants).
15) What is the activity category for this funding opportunity?
The activity category is listed as Health.
16) How many awards were anticipated?
The opportunity anticipated 59 awards.
17) What was the estimated total funding amount for this opportunity?
The estimated total funding amount listed was $1,293,002,000.
18) Is cost sharing or matching required?
No. The notice indicates there is no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of receiving the award.
19) When was this opportunity posted and when did it close?
The notice shows the opportunity was posted on August 25, 2010. The original and current closing date listed is January 3, 2011. The archive date is March 4, 2011.
20) Where can applicants get help or request assistance accessing the full announcement?
HRSA provided support through the HRSA Call Center, including the email address CallCenter@HRSA.GOV and telephone contact options referenced in the posting. The source also included a link to the archived posting on HRSA's grants site.
Browse more opportunities from the same category: Health
Next opportunity: Service Area Competitions
Previous opportunity: CONSTRUCTED WETLAND FOR HABITAT ENHANCEMENT AND SEDIMENT CONTROL
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 11 061
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 11 061) also looked into and applied for these:
| Funding Opportunity |
|---|
| Service Area Competitions Apply for HRSA 11 011 Funding Number: HRSA 11 011 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 012 Funding Number: HRSA 11 012 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 013 Funding Number: HRSA 11 013 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competitions Apply for HRSA 11 014 Funding Number: HRSA 11 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving Evidence Based Mental Health Screening and Treatment for Persons with Mental Disorders in the Justice System (R34) Apply for RFA MH 11 061 Funding Number: RFA MH 11 061 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Improving Evidence Based Mental Health Screening and Treatment for Persons with Mental Disorders in the Justice System (R01) Apply for RFA MH 11 060 Funding Number: RFA MH 11 060 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Orphans and Vulnerable Children (OVC) Program Apply for USAID ETHIOPIA 663 10 000001 RFA Funding Number: USAID ETHIOPIA 663 10 000001 RFA Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $92,106,320 |
| NIDCR Small Grant Program for New Investigators (R03) Apply for PAR 10 275 Funding Number: PAR 10 275 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Rural Health Network Development Program Apply for HRSA 11 089 Funding Number: HRSA 11 089 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Biomarkers of Alcohol Consumption and Alcohol induced Tissue Injury (STTR R41/R42) Apply for RFA AA 11 005 Funding Number: RFA AA 11 005 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Biomarkers of Alcohol Consumption and Alcohol induced Tissue Injury (SBIR R43/R44) Apply for RFA AA 11 004 Funding Number: RFA AA 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| MCH Research Apply for HRSA 11 016 Funding Number: HRSA 11 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Modeling the Scientific Workforce (U01) Apply for RFA GM 11 007 Funding Number: RFA GM 11 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R01) Apply for RFA HG 10 012 Funding Number: RFA HG 10 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R21) Apply for RFA HG 10 013 Funding Number: RFA HG 10 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (SBIR R43/R44) Apply for RFA HG 10 014 Funding Number: RFA HG 10 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Spina Bifida Patient Registry Clinic Demonstration Project (U01) Apply for RFA DD 11 001 Funding Number: RFA DD 11 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $40,000 |
| Ancillary Studies to Large Ongoing Clinical Projects (R01) Apply for RFA AR 11 012 Funding Number: RFA AR 11 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Ancillary Studies to Large Ongoing Clinical Projects (R21) Apply for RFA AR 11 013 Funding Number: RFA AR 11 013 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Protein Structure InitiativeBiology Materials Repository (PSIBiology MR) (U01) Apply for RFA GM 11 008 Funding Number: RFA GM 11 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 11 061", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.